AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SAN FRANCISCO -- Augmenting antidepressant therapy with a medication to treat fatigue may turn some patients who are partial responders into remitters, Dr. Edward Friedman said at a psychopharmacology congress sponsored by the Neuroscience Education Institute.
Augmenting agents that target norepinephrine, dopamine, or histamine may restore energy in patients being treated for depression, said Dr. Friedman, medical director of the depression treatment research program at the University of Pittsburgh Medical Center.
Bupropion, the most popular drug to treat depression-related fatigue, also may boost the antidepressant effects of the primary medication. No…